Amaero director Robert P. Latta reports stock options
One reported option position is scheduled to vest on November 18, 2026, while the other three were fully vested by October 25, 2025.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Amaero Inc. director Robert P. Latta reported four directly held stock-option positions over common stock: 12,500 underlying shares at a $5.32 exercise price, expiring October 31, 2033; 12,500 at $6.95, expiring November 8, 2033; 15,000 at $9.75, expiring November 8, 2027; and 15,000 at $6.46, expiring November 25, 2035. The exercise prices are USD-per-share equivalents converted from AUD grant terms.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| holding | Stock Option (Right to Buy) F2, F4, F3 | -- | -- | -- |
| holding | Stock Option (Right to Buy) F2, F4, F5 | -- | -- | -- |
| holding | Stock Option (Right to Buy) F2, F4, F6 | -- | -- | -- |
| holding | Stock Option (Right to Buy) F2, F4, F7 | -- | -- | -- |
| holding | Common Stock F1 | -- | -- | -- |
Footnotes (7)
- F1. Reflects ownership of Chess Depositary Interests ("CDIs") traded on the Australian Securities Exchange. Each CDI is held by CHESS Depositary Nominees Pty Ltd. and reflects a beneficial interest in 1/40th of a share of the Issuer's common stock.
- F2. All of the outstanding equity awards were granted under and subject to the terms of the Issuer's Employee Incentive Plan. Each grant reflects an option to purchase CDIs, which each are held by CHESS Depositary Nominees Pty Ltd. and reflect a beneficial interest in 1/40th of a share of the Issuer's common stock. The number of shares underlying unexercised options reflect the number of shares of common stock underlying the number of CDIs subject to each equity grant.
- F3. One hundred percent (100%) of the shares subject to the option vested on October 31, 2023.
- F4. The option awards were granted with the equivalent of a per share exercise price equal to the fair market value of one share of the Issuer's common stock on the date of grant, as determined in good faith by the Issuer's board of directors based on third-party valuations of the Issuer's common stock. Exercise price originally granted in $AUD per CDI and converted to USD per share at an exchange rate of $1 AUD for $0.7004 USD, based on the conversion rate as of the June 22, 2026 redomiciliation of the Issuer.
- F5. One hundred percent (100%) of the shares subject to the option vested on October 31, 2024.
- F6. One hundred percent (100%) of the shares subject to the option vested on October 25, 2025.
- F7. One hundred percent (100%) of the shares subject to the option vests on November 18, 2026.
Key Figures
Key Terms
Stock Option (Right to Buy) financial
CHESS Depositary Interests technical
Employee Incentive Plan financial
exercise price financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What stock options did AMRO director Robert P. Latta report?
What does Robert P. Latta's AMRO common-stock holding entry represent?
AI-generated analysis. How Rhea-AI works. Not financial advice.